Archive.fm

Biotech 2050 Podcast

9. The next frontier in cancer treatment: Foghorn Therapeutics and Chromatin Dysregulation

Carl P. Decicco is a biopharmaceutical veteran with over 30+ years of experience in the industry. Over the course of his career, Carl has played a central role in the advancement of more than 200 compounds into clinical trials and the approval of more than 20 drugs across multiple therapeutic areas. He’s authored/Co-Authored more than 100 scientific papers in peer reviewed journals and is listed as an inventor on 26 patents.

Broadcast on:
23 Jan 2020